Safety Rates Drug Report: CLOZAPINE. Hepatic steatosis adverse events in 2016 Q3 - FDA prescription drugs adverse events in an open, searchable, online, public database

2004.Q1 2004.Q2 2004.Q3 2004.Q4 2005.Q1 2005.Q2 2005.Q3 2005.Q4 2006.Q1 2006.Q2 2006.Q3 2006.Q4 2007.Q1 2007.Q2 2007.Q3 2007.Q4 2008.Q1 2008.Q2 2008.Q3 2008.Q4 2009.Q1 2009.Q2 2009.Q3 2009.Q4 2010.Q1 2010.Q2 2010.Q3 2010.Q4 2011.Q1 2011.Q2 2011.Q3 2011.Q4 2012.Q1 2012.Q2 2012.Q3 2012.Q4 2013.Q1 2013.Q2 2013.Q3 2013.Q4 2014.Q1 2014.Q2 2014.Q3 2014.Q4 2015.Q1 2015.Q2 2015.Q3 2015.Q4 2016.Q1 2016.Q2 2016.Q3

Drug Injury Quarter

Drug: CLOZAPINE. Injury: Hepatic steatosis Quarter: 2016Q3

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Event ID	DRUGNAME	PT	Drug Manufacturer	Patient Age	Sex	Weight	Date (YYYYMMDD)	Country
125348181	CLOZAPINE.	Hepatic steatosis		44.00 YR	M	0	20160706	US
127177562	CLOZAPINE.	Hepatic steatosis	JANSSEN	0.00		0	20160913	CN

|< 1/2 << Previous Page Page 1

Total Records: 2 Number of Pages: 1

Execution Time: 0.017846822738647 seconds (ucode:5120647). Developed by: James D. Barger